drugset / Trial / NCT01697787

Amodiaquine-Artesunate & Artemether-Lumefantrine Efficacy in Burkina Faso

NCT01697787

RandomizedParallel-groupOpen-labelTreatment

Summary

This is a two-arm study aiming at recruiting 150 patients to assess the efficacy of Amodiaquine-Artesunate (ASAQ) and Artemether-Lumefantrine (AL) in patients with a microscopy positive diagnosis of malaria in Nanoro, Burkina Faso and assess the performance of the Rapid Diagnosis Tests (RDTs) compared to the microscopy.

Timeline

Start
2012-10
Primary completion
2014-09
Completion
2014-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Artemether Small molecule 20 mg Oral
Subject Artesunate Small molecule Oral
Subject amodiaquine Other / unclassified Oral
Subject lumefantrine Small molecule 120 mg Oral